-
China Sky One Medical Updates Financial Guidance for 2010
HARBIN, China, Sept. 3 /PRNewswire-Asia-FirstCall/ -- China Sky One
Medical, Inc. ("China Sky One Medical" or "the Company") (Nasdaq: CSKI), a
leading fully integrated pharmaceutical company in the People's Republic of
China ("PRC"), today announced that its fiscal year 2010 revenue and adjusted
-
Maryland Stem Cell Research Commission to Host Third Annual Maryland Stem Cell Research Symposium
COLUMBIA, Md., Sept. 3 /PRNewswire/ -- The Maryland Stem Cell Research Commission (Commission) will host the Third Annual Maryland Stem Cell Research Symposium in partnership with the National Institutes of Health (NIH) and the National Institute of Standards and Technology (NIST) on Wednesday, Sept
-
China-Biotics Announces September 20 Investor Day Schedule
SHANGHAI, Sept. 3 /PRNewswire-Asia-FirstCall/ -- China-Biotics, Inc.
("China-Biotics", the "Company") (Nasdaq: CHBT), the leading developer,
manufacturer and distributor of probiotics products in China, today announced
the schedule for the Investor Day, which will be held on Monday, September 20
-
Medical Affairs Report Outlines Resource Needs for Group Success
CHAPEL HILL, N.C., Sept. 3 /PRNewswire/ -- The Medical Affairs function arguably plays the most critical role in a biopharmaceutical organization, with heavy responsibilities across areas such as clinical development, scientific publications, KOL development, and medical education. These areas must
-
Waters Corporation and UCLA to Convene Leading Life Scientists
MILFORD, Mass., Sept. 3 /PRNewswire/ -- Waters Corporation (NYSE: WAT) and the University of California at Los Angeles (UCLA) will bring together some of the world's leading life science researchers and practitioners of mass spectrometry (MS) at a conference next month to discuss the ways they are a
-
China Cord Blood Corporation to Announce First Quarter Fiscal 2011 Financial Results
HONG KONG, Sept. 3 /PRNewswire-Asia-FirstCall/ -- China Cord Blood
Corporation (NYSE: CO; "the Company") today announced its plan to release
financial results for the first quarter of fiscal year 2011 on Friday,
September 10, 2010, before the market opens in the US.
The Company will hold a
-
Tibotec Pharmaceuticals Seeks European Marketing Authorization for Investigational Once-Daily HIV Treatment TMC278
CORK, Ireland, September 3, 2010 /PRNewswire/ -- Tibotec Pharmaceuticals
today announced its submission of a Marketing Authorisation Application (MAA)
to the European Medicines Agency (EMA) for TMC278 (rilpivirine, as
hydrochloride), an investigational non-nucleoside reverse transcriptase
inhibi
-
The Female Health Company to Present at Rodman & Renshaw's Annual Global Investment Conference on Wednesday, September 15, 2010
CHICAGO, Sept. 3 /PRNewswire/ -- The Female Health Company (Nasdaq: FHCO), which manufactures and markets the FC2 Female Condom®, today announced that the Company's CEO, O.B. Parrish, and its CFO, Donna Felch, are scheduled to make a presentation at Rodman & Renshaw's Global Investment Conf
-
ForteBio Announces Launch of Protein G Biosensor for Use on Company's Octet® Instruments
MENLO PARK, Calif., Sept. 3 /PRNewswire/ -- ForteBio®, Inc., a leading supplier of label-free technology that accelerates the development of biotherapeutic and pharmaceutical products, today announced the launch of its Dip and Read™ Protein G biosensor for rapid detection and quantificati
-
New Report - U.S. Digestive Health Ingredients Markets (2010 - 2015) - MarketsandMarkets
DALLAS, Texas, September 3, 2010 /PRNewswire/ -- Buy this report now:
http://www.marketsandmarkets.com/Market-Reports/digestive-health-ingredients-
225.html
(Due to the length of this URL, it may be necessary to copy and paste
this hyperlink into your Internet browser's URL address field. R
-
American Society for Biochemistry and Molecular Biology Reacts to District Court Stem-Cell Ruling
BETHESDA, Md., Sept. 2 /PRNewswire-USNewswire/ -- The American Society for Biochemistry and Molecular Biology expressed its disapproval and disappointment this week in response to the Aug. 23 ruling in the U.S. District Court for the District of Columbia that granted a preliminary injunction barring
-
Sequenom to Present at Two Financial Conferences in September
SAN DIEGO, Sept. 2 /PRNewswire-FirstCall/ -- Sequenom, Inc. (Nasdaq: SQNM) today announced that Ronald M. Lindsay, PhD, executive vice president of research and development, will present an overview of the company at the following conferences in September.
(Logo: http://photos.prnewswire.com/p
-
Celsion Receives SBIR Grant To Expand Its Technology Platform
COLUMBIA, Md., Sept. 2 /PRNewswire-FirstCall/ --Celsion Corporation (Nasdaq: CLSN), a biotechnology drug development company, announced today that it has been awarded a competitive Phase I Small Business Innovation and Research (SBIR) grant from the National Institutes of Health (NIH), to support th
-
Sales Success Shows Neuromarketing Moves Magazines: New Scientist Reports 12% Increase in Newsstand Sales for Issue Featuring NeuroFocus-Tested Cover Design
LONDON , Sept. 2 /PRNewswire/ -- For marketers everywhere, especially consumer goods companies for whom packaging is a critical determinant of success, the question asked has now been definitively answered: neuromarketing can increase sales—substantially.
When New Scientist approached NeuroFoc
-
Mark S. Rangell Appointed Chief Operating Officer for Sandata Technologies, LLC
PORT WASHINGTON, N.Y., Sept. 2 /PRNewswire/ -- Sandata Technologies, LLC, a leading national provider of information technology solutions to the home healthcare community, today announced the hiring of Mark S. Rangell as its Chief Operating Officer. Mr. Rangell will be in charge of Sandata's day-to-
-
Professor Leroux From ETH Receives the Debiopharm Life Sciences Award 2010
LAUSANNE, Switzerland, September 2, 2010 /PRNewswire/ -- Debiopharm
Group(TM) (Debiopharm), a Swiss-based global biopharmaceutical group of
companies with a focus on the development of innovative prescription drugs
that target unmet medical needs, today announced that the 'Debiopharm Life
Scienc
-
Statement From Sicel Technologies, Inc.
RALEIGH, N.C., Sept. 2 /PRNewswire/ -- Sicel Technologies, Inc., announced today that the organization has not been placed into involuntary bankruptcy. Effective August 31, 2010, Paul McDaniel became the interim President and an interim Director of the company. Currently, Sicel's operations are cont
-
AloeSafe™ Hand Sanitizer is Free From Toxic Chemicals
SANTA MARIA, Calif., Sept. 2 /PRNewswire/ -- Hardy Diagnostics, an FDA licensed and ISO certified biomedical firm, is pleased to announce the release of AloeSafe™, a hand sanitizer that contains aloe vera, vitamin E, and lavender oil. Unlike most alcohol based hand sanitizers, AloeSafe™
-
Cetero Research Launches Seminar Series on Accelerated Proof-of-Concept in Drug Development
CARY, N.C., Sept. 2 /PRNewswire/ -- Cetero Research, the leading early-stage contract research organization (CRO), is launching a series of scientific seminars, "An Accelerated Path to Proof-of-Concept in Drug Development," designed to help pharmaceutical and biotechnology researchers learn the late
-
New Research Demonstrates Safety of Cord-blood-derived Stem Cell Treatments
SHENZHEN, China, Sept. 2 /PRNewswire-Asia/ -- In a new peer-reviewed
article published by the Journal of Translational Medicine, scientists from
Beike Biotechnology ( http://www.beikebiotech.com/ ), China's leading stem
cell research and regenerative medicine company, and Medistem, Inc. (Pink
Sh
|